WEST PHARMACEUTICAL SERVICES, INC. Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount of -$4.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Income Taxes
us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount · last filed 2026-02-17
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2024-03-31 was -$10.90M.
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2023-03-31 was -$11.60M.
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2022-03-31 was -$8.90M.
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2021-03-31 was -$11.10M.
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2025 was -$4.50M.
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2024 was -$19.50M.
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2023 was -$32.00M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 3 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 12 month |
|---|---|---|
| 2025-12-31 | -$4.50M 10-K · filed 2026-02-17 | |
| 2024-12-31 | -$19.50M 10-K · filed 2026-02-17 | |
| 2024-03-31 | -$10.90M 10-Q · filed 2024-04-25 | |
| 2023-12-31 | -$32.00M 10-K · filed 2026-02-17 | |
| 2023-03-31 | -$11.60M 10-Q · filed 2024-04-25 | |
| 2022-03-31 | -$8.90M 10-Q · filed 2023-04-27 | |
| 2021-03-31 | -$11.10M 10-Q · filed 2022-04-28 | |
| 2020-03-31 | -$5.10M 10-Q · filed 2021-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |